Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection
Date
2022-03-01
Language
English
Embargo Lift Date
Department
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Elsevier
Abstract
Postacute sequelae of SARS-CoV2 (PASC) infection is an emerging global health crisis, variably affecting millions worldwide. PASC has no established treatment. We describe 2 cases of PASC in response to opportune administration of over-the-counter antihistamines, with significant improvement in symptoms and ability to perform activities of daily living. Future studies are warranted to understand the potential role of histamine in the pathogenesis of PASC and explore the clinical benefits of antihistamines in the treatment of PASC.
Description
Keywords
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Pinto, M. D., Lambert, N., Downs, C. A., Abrahim, H., Hughes, T. D., Rahmani, A. M., Burton, C. W., & Chakraborty, R. (2022). Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection. The Journal for Nurse Practitioners, 18(3), 335–338. https://doi.org/10.1016/j.nurpra.2021.12.016
ISSN
1555-4155
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
The Journal for Nurse Practitioners
Source
Publisher
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
Version
Final published version